Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group.
Defina M, Lazzarotto D, Guolo F, Minetto P, Fracchiolla NS, Giglio F, Forghieri F, Vitale A, Chiaretti S, Papayannidis C, Piccini M, Mulè A, Bocchia M, Leoncin M, Gurrieri C, Aprile L, Lunghi M, Bonifacio M, Pasciolla C, Cerrano M, Fumagalli M, Foà R, Candoni A. Defina M, et al. Among authors: aprile l. Leuk Res. 2022 Nov;122:106963. doi: 10.1016/j.leukres.2022.106963. Epub 2022 Sep 21. Leuk Res. 2022. PMID: 36155352 No abstract available.
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
Defina M, Ippoliti M, Gozzetti A, Abruzzese E, Castagnetti F, Crupi R, Tiribelli M, Breccia M, Salvucci M, Aprile L, Baratè C, Gozzini A, Rosti G, Lauria F, Bocchia M. Defina M, et al. Among authors: aprile l. Cancer. 2012 Nov 1;118(21):5265-9. doi: 10.1002/cncr.27506. Epub 2012 Apr 19. Cancer. 2012. PMID: 22517301 Free article.
Peptide vaccines for hematological malignancies: a missed promise?
Bocchia M, Defina M, Aprile L, Sicuranza A. Bocchia M, et al. Among authors: aprile l. Int J Hematol. 2014 Feb;99(2):107-16. doi: 10.1007/s12185-013-1497-3. Epub 2014 Jan 8. Int J Hematol. 2014. PMID: 24399190 Free article. Review.
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.
Bocchia M, Galimberti S, Aprile L, Sicuranza A, Gozzini A, Santilli F, Abruzzese E, Baratè C, Scappini B, Fontanelli G, Trawinska MM, Defina M, Gozzetti A, Bosi A, Petrini M, Puccetti L. Bocchia M, et al. Among authors: aprile l. Oncotarget. 2016 Nov 1;7(44):72311-72321. doi: 10.18632/oncotarget.11100. Oncotarget. 2016. PMID: 27527867 Free PMC article.
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia.
Zappone E, Defina M, Aprile L, Bartalucci G, Gozzetti A, Bocchia M. Zappone E, et al. Among authors: aprile l. Anticancer Agents Med Chem. 2017;17(8):1028-1032. doi: 10.2174/1871520616666161010162737. Anticancer Agents Med Chem. 2017. PMID: 27748173 Review.
Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.
Bocchia M, Sicuranza A, Abruzzese E, Iurlo A, Sirianni S, Gozzini A, Galimberti S, Aprile L, Martino B, Pregno P, Sorà F, Alunni G, Fava C, Castagnetti F, Puccetti L, Breccia M, Cattaneo D, Defina M, Mulas O, Baratè C, Caocci G, Sica S, Gozzetti A, Luciano L, Crugnola M, Annunziata M, Tiribelli M, Pacelli P, Ferrigno I, Usala E, Sgherza N, Rosti G, Bosi A, Raspadori D. Bocchia M, et al. Among authors: aprile l. Front Oncol. 2018 May 30;8:194. doi: 10.3389/fonc.2018.00194. eCollection 2018. Front Oncol. 2018. PMID: 29900128 Free PMC article.
64 results